Legacy Wealth Asset Management’s Mustang Bio MBIO Stock Holding History

Legacy Wealth Asset Management’s Portfolio MBIO Stock Details MBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-27	Closed	-$7.33K	–	343
2023 Q1	$7.33K	Hold	27	–	–	﹤0.01%	334
2022 Q4	$7.9K	Hold	27	–	–	﹤0.01%	334
2022 Q3	$9K	Hold	27	–	–	﹤0.01%	313
2022 Q2	$12K	Buy	+27	New	+$14.9K	﹤0.01%	321

Other funds holding MBIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KOC

Koss-Olinger Consulting Gainesville, Florida $1.19B AUM 15.91% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Legacy Wealth Asset Management's MBIO Position: Q2 2023 in Review

Legacy Wealth Asset Management sold out of Mustang Bio (MBIO) in Q2 2023, closing a stake of 27 shares — an estimated $7.33K sold.

Legacy Wealth Asset Management first reported a position in MBIO in Q2 2022 and held it in 4 quarters. The position peaked at $12K in Q2 2022. 27 funds tracked by Wall St. Rank hold MBIO as of Q2 2023.

Legacy Wealth Asset Management reported no remaining Mustang Bio position as of Q2 2023 after selling out during the quarter.
Legacy Wealth Asset Management sold 27 Mustang Bio shares in Q2 2023, an estimated $7.33K.
Legacy Wealth Asset Management first reported a position in Mustang Bio in Q2 2022 and held it in 4 quarters.
Legacy Wealth Asset Management's Mustang Bio position peaked at $12K in Q2 2022.
27 funds tracked by Wall St. Rank held Mustang Bio as of Q2 2023.

Based on Legacy Wealth Asset Management's 13F filing for Q2 2023, filed 4 Aug 2023.